According to Reuters, the Wall Street Journal reported on October 14 that Biotec Company (CNBG), a subsidiary of state-owned Sinopharm Group Co Ltd, is developing two COVID-19 vaccines that will provide free of charge. for these Chinese students graduate study abroad.
According to the newspaper, the move by CNBG is to increase people’s confidence in domestic vaccination, as well as more information about the company’s website and some students registered to receive the vaccine.
Before that, CNBG announced the job vaccine distribution for the students on the site and everyone can sign up for.
[Trung Quốc bắt đầu thử nghiệm vắcxin phòng COVID-19 trên người]
As of October 12, 418,613 people had received the vaccine, while an additional 93,653 people had registered to get the vaccine.
However, the site was discontinued on October 13 and is “under maintenance.” CNBG did not respond to Reuters’ comment on this matter.
China launched its emergency vaccination program in July, providing three experimental vaccines, produced by a subsidiary of China National Pharmaceutical Corporation and the US Sinovac Biotech Company.
A fourth vaccine developed by CanSino Biologics was approved by the Chinese military in June.
In addition, a cloud computing and artificial intelligence company based in Abu Dhabi (United Arab Emirates, UAE) called Group 42 is completing a phase 3 clinical trial of a conjugate vaccine. production with CNBG./.